充血性心肌病慢性口服β受体阻滞剂的双盲试验 - Suppr

Suppr

超能文献

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.

作者信息

Ikram H, Fitzpatrick D

出版信息

Lancet. 1981 Sep 5;2(8245):490-3. doi: 10.1016/s0140-6736(81)90881-3.

DOI:10.1016/s0140-6736(81)90881-3

PMID:6115247

Abstract

摘要

相似文献

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.

Lancet. 1981 Sep 5;2(8245):490-3. doi: 10.1016/s0140-6736(81)90881-3.

Therapeutic controversies with use of beta-adrenoceptor blockade in heart failure.

Am J Cardiol. 1993 Mar 25;71(9):54C-60C. doi: 10.1016/0002-9149(93)90087-s.

Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.

Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):598-600.

beta-blockade in cardiomyopathy.

Lancet. 1981;2(8260-61):1421. doi: 10.1016/s0140-6736(81)92835-x.

[Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].

Kardiol Pol. 1987;30(7):409-18.

Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle.

Circulation. 1978 Sep;58(3 Pt 1):449-60. doi: 10.1161/01.cir.58.3.449.

[Cardiomyopathies, nonspecific myocarditis and alcoholic heart lesions (data from the clinical study of 100 patients)].

Ter Arkh. 1984;56(9):75-81.

[Electrophysiological properties of injectable acebutolol. A study of one case of auriculo-ventricular block observed under acebutolol per os (author's transl)].

Ann Cardiol Angeiol (Paris). 1979 Jul-Sep;28(4):261-8.

Congestive cardiomyopathy: therapeutic approach.

Compr Ther. 1982 Jul;8(7):25-34.

[Hemodynamic effects of the association of nifedipine and acebutolol].

Arch Mal Coeur Vaiss. 1982 Mar;75(3):317-23.

引用本文的文献

Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.

Handb Exp Pharmacol. 2024;285:247-295. doi: 10.1007/164_2024_720.

Redefining biomarkers in heart failure.

Heart Fail Rev. 2018 Mar;23(2):237-253. doi: 10.1007/s10741-018-9683-2.

Measurement of the quality of life in congestive heart failure-Influence of drug therapy.

Cardiovasc Drugs Ther. 1988 Nov;2(Suppl 1):419-424. doi: 10.1007/BF00633423.

Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.

Heart Fail Clin. 2014 Oct;10(4):543-57. doi: 10.1016/j.hfc.2014.07.002. Epub 2014 Aug 14.

Beta-blockers for congestive heart failure: what is the current consensus?

Drugs Aging. 2000 Jan;16(1):1-7. doi: 10.2165/00002512-200016010-00001.

Outpatient management of congestive heart failure.

Tex Heart Inst J. 1998;25(4):238-50.

Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group.

Heart. 1998 Apr;79(4):337-44. doi: 10.1136/hrt.79.4.337.

[Cost effectiveness of bisoprolol in heart failure. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study (CIBIS) for Germany].

Med Klin (Munich). 1997 Aug 15;92(8):499-504. doi: 10.1007/BF03044920.

The role of beta-blockers in left ventricular dysfunction and heart failure.

Drugs. 1997 Oct;54(4):501-10. doi: 10.2165/00003495-199754040-00001.

Beta blockers and the failing heart: is it time for a U-turn?

Br Heart J. 1993 Jul;70(1):8-12. doi: 10.1136/hrt.70.1.8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验